What's Going On With Portage Biotech Shares Tuesday?
What's Going On With Portage Biotech Shares Tuesday?
Portage Biotech Inc. (NASDAQ:PRTG) stock is trading higher after the company announced it signed a letter of intent with Immunova, LLC for the potential sale of its subsidiary.
Portage Biotech Inc.(纳斯达克股票代码:PRTG)宣布与Immunova, LLC签署了可能出售其子公司的意向书后,该公司股价走高。
The Details: According to the letter of intent, Portage and Immunova have agreed to negotiate a definitive option agreement for Immunova to acquire Portage's subsidiary, iOx Therapeutics, Ltd.
详情:根据意向书,Portage和Immunova已同意就Immunova收购Portage的子公司ioX Therapeutics, Ltd的最终期权协议进行谈判。
iOx specializes in developing liposomal iNKT agonists, with its lead candidate, PORT-2, showing encouraging early clinical results.
ioX 专门开发脂质体 InkT 激动剂,其主要候选药物 port-2 显示出令人鼓舞的早期临床结果。
Brian Horsburgh, PhD, CEO of Immunova, said: "We are delighted to continue our collaboration with Portage and potentially add the iOx assets to our own pipeline, creating a clinical-stage biotech company focused on lipid drugs and delivery systems that empower immune cells to better fight disease. This acquisition represents a leap in our mission to advance innovative therapies to patients who need them most."
Immunova首席执行官布莱恩·霍斯堡博士表示:“我们很高兴继续与Portage合作,并有可能将IoX资产添加到我们自己的产品线中,从而创建一家临床阶段的生物技术公司,专注于脂质药物和赋予免疫细胞更好地对抗疾病的递送系统。此次收购代表了我们向最需要的患者推进创新疗法的使命的飞跃。”
Portage stock is trading with unusually high volume, reaching 30.816 million shares. The average session volume over the past 100 days is 899.38 thousand shares.
Portage股票的交易量异常高,达到3081.6万股。过去100天的平均交易量为89.938万股。
PRTG Price Action: At the time of writing, Portage shares are trading 232.6% higher at $10.75, according to data from Benzinga Pro.
PRTG价格走势:根据Benzinga Pro的数据,在撰写本文时,Portage股价上涨232.6%,至10.75美元。
Image: Image: Emilian Danaila from Pixabay
图片:图片:来自 Pixabay 的 Emilian Danaila